274
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Red Cell Distribution Width/Albumin Ratio: A Predictor of In-Hospital All-Cause Mortality in Patients with Acute Myocardial Infarction in the ICU

, , ORCID Icon, &
Pages 745-756 | Received 21 Oct 2022, Accepted 17 Feb 2023, Published online: 27 Feb 2023

References

  • Damar İH, Eroz R. The association of hereditary prothrombotic risk factors with ST-elevation myocardial infarction. Medeni Med J. 2020;35:295–303. doi:10.5222/MMJ.2020.67366
  • Santos-Gallego CG, Picatoste B, Badimón JJ. Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep. 2014;16(4):401. doi:10.1007/s11883-014-0401-9
  • Tomandlova M, Jarkovsky J, Tomandl J, et al. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress. Dis Markers. 2015;2015:159051. doi:10.1155/2015/159051
  • Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi:10.1093/eurheartj/ehx393
  • Kimura K, Kimura T, Ishihara M, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83(5):1085–1196. doi:10.1253/circj.CJ-19-0133
  • Ries W, Torzewski J, Heigl F, et al. C-reactive protein apheresis as anti-inflammatory therapy in acute myocardial infarction: results of the CAMI-1 study. Front Cardiovasc Med. 2021;8:591714. doi:10.3389/fcvm.2021.591714
  • Qi LY, Liu HX, Cheng LC, et al. Prognostic value of the leuko-glycemic index in acute myocardial infarction patients with or without diabetes. Diabetes Metab Syndr Obes. 2022;9(15):1725–1736. doi:10.2147/DMSO.S356461
  • Cemin R, Donazzan L, Lippi G, et al. Blood cells characteristics as determinants of acute myocardial infarction. Clin Chem Lab Med. 2011;49(7):1231–1236. doi:10.1515/CCLM.2011.183
  • Ilhan E, Güvenç TS, Altay S, et al. Predictive value of red cell distribution width in intrahospital mortality and postintervention thrombolysis in myocardial infarction flow in patients with acute anterior myocardial infarction. Coron Artery Dis. 2012;23(7):450–454. doi:10.1097/MCA.0b013e3283587897
  • Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010;105(3):312–317. doi:10.1016/j.amjcard.2009.09.027
  • González-Pacheco H, Luis M, Sandoval J, et al. Prognostic implications of serum albumin levels in patients with acute coronary syndromes. Am J Cardiol. 2017;119(7):951–958. doi:10.1016/j.amjcard.2016.11.054
  • Zhu L, Chen M, Lin X. Serum albumin level for prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis. Biosci Rep. 2020;40(1):BSR20190881. doi:10.1042/BSR20190881
  • Chen L, Lu XY, Zhu CQ. Prognostic value of albumin-red cell distribution width score in patients with severe community-acquired pneumonia. Ann Palliat Med. 2020;9(3):759–765. doi:10.21037/apm.2020.04.22
  • Yoo J-W, Sunmi J, Lee SJ, et al. Red cell distribution width/albumin ratio is associated with 60-day mortality in patients with acute respiratory distress syndrome. Infect Dis. 2020;52(4):266–270. doi:10.1080/23744235.2020.1717599
  • Zhou D, Wang J, Xiaokun L. The red blood cell distribution width-albumin ratio was a potential prognostic biomarker for diabetic ketoacidosis. Int J Gen Med. 2021;14:5375–5380. doi:10.2147/IJGM.S327733
  • Thygesen K, Alpert JS, Jaffe AS, et al. Executive group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
  • Arbel Y, Birati EY, Finkelstein A, et al. Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization. J Thromb Thrombolysis. 2014;37(4):469–474. doi:10.1007/s11239-013-0964-2
  • Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105. doi:10.3109/10408363.2014.992064
  • Uyarel H, Ergelen M, Cicek G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011;22(3):138–144. doi:10.1097/MCA.0b013e328342c77b
  • Azab B, Torbey E, Hatoum H, et al. Usefulness of red cell distribution width in predicting all-cause long-term mortality after non-ST-elevation myocardial infarction. Cardiology. 2011;119(2):72–80. doi:10.1159/000329920
  • Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628–632. doi:10.5858/133.4.628
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra043430
  • Yčas JW, Horrow JC, Horne BD. Persistent increase in red cell size distribution width after acute diseases: a biomarker of hypoxemia? Clin Chim Acta. 2015;448:107–117. doi:10.1016/j.cca.2015.05.021
  • Allen LA, Michael Felker G, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16(3):230–238. doi:10.1016/j.cardfail.2009.11.003
  • Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM199902113400607
  • Eckart A, Struja T, Kutz A, et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med. 2020;133(6):713–722. doi:10.1016/j.amjmed.2019.10.031
  • Mukai H, Villafuerte H, Qureshi AR, et al. Serum albumin, inflammation, and nutrition in end-stage renal disease: c-reactive protein is needed for optimal assessment. Semin Dial. 2018;31(5):435–439. doi:10.1111/sdi.12731
  • Bozkurt E, Ucak T. Serum inflammation biomarkers in patients with keratoconus. Ocul Immunol Inflamm. 2020;7:1–4.
  • Suzuki S, Hashizume N, Kanzaki Y, et al. Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention. PLoS One. 2019;14(7):e0219044. doi:10.1371/journal.pone.0219044
  • Hartopo AB. Putrika Prastuti Ratna Gharini, Budi Yuli Setianto. Int Heart J. 2010;51(4):221–226.
  • Polat N, Oylumlu M, Işik MA, et al. Prognostic Significance of Serum Albumin in Patients With Acute Coronary Syndrome. Angiology. 2020;71(10):903–908. doi:10.1177/0003319720941747
  • Plakht Y, Gilutz H, Shiyovich A. Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Int J Cardiol. 2016;219:20–24.
  • Tong L, Liu Y, Shen JH, et al. Relationship between the red cell distribution width-to-platelet ratio and in-hospital mortality among critically ill patients with acute myocardial infarction: a retrospective analysis of the MIMIC-IV database. BMJ Open. 2022;12:e062384. doi:10.1136/bmjopen-2022-062384